이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Emergency Medical Technician Treat-and-leave Patients Receiving Telemedicine Consultation With Emergency Medical Dispatch Physician - a Controlled Before and After Pilot-study

2015년 12월 8일 업데이트: University of Aarhus

A large part of acutely ill patient's access to the health care system starts by calling the emergency number 1-1-2 and thereby getting in touch with the emergency medical dispatch center (EMDC). In most cases an ambulance is dispatched and the patient is brought to the hospital. These patients are not referred by a physician (eg. a GP) and represent an unselected subpopulation of the acutely ill patients. At present, all non-critically ill patients not evaluated by a pre-hospital physician are normally be transported to hospital as category 2 (without activated emergency lightning and sirens).A part of this patient population, however, is not critically ill and a proportion of these may not need hospital admittance . Emergency medical technicians (EM) are not allowed to treat - and- leave patients without a physician's involvement. If the EMT had 24/7 online access to medical control i.e. in form of a physician present in the EMDC , the number of patients transported to hospital for assessment may be reduced as well as response times for patients actually needing ambulance transportation. This could potentially reduce the workload on the whole healthcare system involved in the management of these patients - thereby potentially reducing costs.

The objective of this study is to evaluate if a systematic telemedical assessment by an EMDC-physician of all patients who receive an ambulance but are not critically ill and would have a category 2 transport to hospital can reduce the number of the patients that are transported to hospital and save costs and time.

연구 개요

상태

완전한

연구 유형

중재적

등록 (실제)

774

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

      • Aarhus N, 덴마크, 8200N
        • Prehospital Emergency Medical Services, Aarhus

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

  • 어린이
  • 성인
  • 고령자

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion Criteria:

  • Patients receiving an emergency ambulance after calling the EMDC Patients who are going to be admitted to a Hospital in the Central Denmark Region.
  • Patients who are going to be transported as category 2 patients (non-critical illness, not requiring transport with activated lightning and sirens.

Exclusion Criteria:

  • Critically ill patients (Patients who are going to be transported as category 1 patients (critical-illness, requiring immediate transport with activated sirens and warning lights )
  • Patients who are not supposed to be admitted to a hospital in the Central Denmark Region

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 치료
  • 할당: 해당 없음
  • 중재 모델: 단일 그룹 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Telemedicine consultation
EMTs will systematically establish teleconsultation by either telephone or video with the EMDC-physician in all cases of non-critical illness
Telemedicine consultation done by telephone or video
다른 이름들:
  • For video consultation iPAD AIR 4G/3G 16 GB will be used.
  • LifeSize ClearSea solution will be used for videoconferencing.
  • 4G/3G mobile network.
  • For telephone consultation Nokia C2-01 GSM telephone will be used.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Expenses related to EMDC physician vs. savings obtained by avoided admissions
기간: Will be assessed at the time of consultation, expected to be presented within 36 months after assessment
Cost of 24 hour EMDC physician vs. savings obtained by avoided admissions. Calculations of average transport related costs will be provided by the Prehospital Emergency Medical Services Aarhus and average cost of hospitalization for a patient hospitalized 24 hours or less at the emergency dept. will be provided by the Regional Hospital Horsens. The percentage of treat-and-leave patients in the intervention period will be compared to a historical control group represented by the average percentage of treat-and-leave patients for the previous 12 months (August 2013 to August 2014). The savings obtained by avoided admissions will be calculated by multiplying the difference in the proportion of treat and leave patients with the number of patients the previous 12 months who are receiving an ambulance after dialing 112. The EMDC physician related costs will be calculated from the present table of salary for specialist physicians in Denmark.
Will be assessed at the time of consultation, expected to be presented within 36 months after assessment

2차 결과 측정

결과 측정
측정값 설명
기간
Percentage of avoided hospital admissions
기간: Treated-and-left or not will be assessed at the time of consultation, expected to be presented within 36 months of assessment
Is the difference in percentage of treat-and-leave patients in the intervention period and historical control period
Treated-and-left or not will be assessed at the time of consultation, expected to be presented within 36 months of assessment
Response time for ambulances
기간: Is assessed at the time the EMT registers arrival on site, expected to be presented within 36 months of assessment
Defined as the average response time for ambulances dispatched by EMDC. The average response time is calculated as the time where the emergency medical dispatcher gets an assignment (registered manually by the dispatcher) to the arrival of the ambulance at scene (registered manually by the EMS technician). This definition of response time is predefined politically and is the gold standard for this measurement across dispatch centers in Denmark.
Is assessed at the time the EMT registers arrival on site, expected to be presented within 36 months of assessment
Hospital admission within 3 days
기간: Will be assessed at the 72 hours after consultation, expected to be presented within 36 months of assessment
Percentage of patients where initial hospital admission is avoided, but are admitted to hospital within 72 hours after primary contact.
Will be assessed at the 72 hours after consultation, expected to be presented within 36 months of assessment
Time consumption by EMDC physician
기간: Will be assessed within 1 minute after end of consultation, expected to be presented within 36 months after assessment
Registered as the time from receiving phone call or establishing video contact to connection is discontinued
Will be assessed within 1 minute after end of consultation, expected to be presented within 36 months after assessment
Cause of death
기간: Will be assessed as soon as possible after the occurence of death, normally within 24 hours, expected to be presented within 36 months of assessment
Audit on all patients dying within 30 days of primary contact. Patient's electronic medical record will be assessed by two independent consultant physicians with no relation to EMDC in order to evaluate if death of a treat-and-leave patient can be attributed to treat-and-leave
Will be assessed as soon as possible after the occurence of death, normally within 24 hours, expected to be presented within 36 months of assessment
Patient's evaluation
기간: Will be assessed within 72 hours after end of consultation, expected to be presented within 36 months after assessment
Patient's evaluation of prehospital care. Telephone survey of all included patients in the intervention period will be conducted within 72 hours after teleconsultation with EMDC-physician
Will be assessed within 72 hours after end of consultation, expected to be presented within 36 months after assessment

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작

2014년 9월 1일

기본 완료 (실제)

2014년 11월 1일

연구 완료 (실제)

2014년 11월 1일

연구 등록 날짜

최초 제출

2014년 7월 11일

QC 기준을 충족하는 최초 제출

2014년 8월 26일

처음 게시됨 (추정)

2014년 8월 29일

연구 기록 업데이트

마지막 업데이트 게시됨 (추정)

2015년 12월 9일

QC 기준을 충족하는 마지막 업데이트 제출

2015년 12월 8일

마지막으로 확인됨

2014년 7월 1일

추가 정보

이 연구와 관련된 용어

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다